Colgate-Palmolive (CL)
91.86
0.69 (0.76%)
At close: Mar 03, 2025, 11:25 AM
Colgate-Palmolive Revenue Breakdown
| Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oral, Personal and Home Care Revenue | 3.91B | 3.94B | 3.96B | 3.83B | 3.86B | 3.77B | 3.71B | 3.57B | 3.58B | 3.58B | 3.53B | 3.52B | 3.57B | 3.47B | 3.56B | 3.54B | 3.45B | 3.23B | 3.38B | 3.34B | 3.29B | 3.25B | 3.28B | 3.18B | 3.26B | 3.29B | 3.42B | 3.3B | 3.4B | 3.25B | 3.21B | 3.14B | 3.31B | 3.27B | 3.21B | 3.32B | 3.45B | 3.51B | 3.53B | 3.65B | 3.81B | 3.79B | 3.77B | 3.78B | 3.85B | 3.8B | 3.78B | 3.73B | 3.8B | 3.74B | 3.66B |
| Oral, Personal and Home Care Revenue Growth | -0.94% | -0.48% | +3.34% | -0.57% | +2.42% | +1.54% | +3.92% | -0.39% | +0.22% | +1.36% | +0.28% | -1.46% | +2.97% | -2.59% | +0.62% | +2.52% | +6.95% | -4.53% | +1.26% | +1.24% | +1.29% | -0.94% | +3.24% | -2.51% | -0.94% | -3.63% | +3.61% | -3.00% | +4.52% | +1.43% | +2.10% | -4.96% | +1.01% | +1.96% | -3.40% | -3.76% | -1.74% | -0.51% | -3.10% | -4.41% | +0.55% | +0.53% | -0.16% | -1.95% | +1.47% | +0.42% | +1.45% | -2.02% | +1.82% | +2.13% | n/a |
| Pet Nutrition Revenue | 1.13B | 1.11B | 1.1B | 1.11B | 1.06B | 1.06B | 1.06B | 1.06B | 872M | 909M | 872M | 886M | 845M | 794M | 786M | 788M | 704M | 672M | 719M | 679M | 633M | 613M | 600M | 630M | 582M | 592M | 584M | 593M | 573M | 572M | 554M | 579M | 561M | 572M | 552M | 576M | 546M | 552M | 538M | 576M | 566M | 560M | 553M | 583M | 545M | 549M | 534M | 559M | 528M | 531M | 542M |
| Pet Nutrition Revenue Growth | +1.08% | +1.09% | -1.17% | +5.39% | +0.19% | -0.47% | +0.09% | +21.56% | -4.07% | +4.24% | -1.58% | +4.85% | +6.42% | +1.02% | -0.25% | +11.93% | +4.76% | -6.54% | +5.89% | +7.27% | +3.26% | +2.17% | -4.76% | +8.25% | -1.69% | +1.37% | -1.52% | +3.49% | +0.17% | +3.25% | -4.32% | +3.21% | -1.92% | +3.62% | -4.17% | +5.49% | -1.09% | +2.60% | -6.60% | +1.77% | +1.07% | +1.27% | -5.15% | +6.97% | -0.73% | +2.81% | -4.47% | +5.87% | -0.56% | -2.03% | n/a |
Revenue by Geography
| Quarter | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|
| Oral, Personal And Home Care Revenue | 4.64B | 3.98B | 3.69B | 3.74B | 3.61B | 3.6B |
| Oral, Personal And Home Care Revenue Growth | +16.52% | +7.80% | -1.26% | +3.74% | +0.03% | n/a |
| Pet Nutrition Revenue | 2.92B | 2.43B | 2.02B | 1.71B | 1.44B | 1.3B |
| Pet Nutrition Revenue Growth | +19.98% | +20.52% | +17.87% | +18.81% | +10.51% | n/a |
Operating Expense Breakdown
| Quarter | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.9B | 1.98B | 1.91B | 1.88B | 1.8B | 1.82B | 1.77B | 1.76B | 1.63B | 1.63B | 1.66B | 1.64B | 1.6B | 1.64B | 1.57B | 1.6B | 1.63B | 1.52B | 1.4B | 1.47B | 1.41B | 1.43B | 1.37B | 1.36B | 1.33B | 1.37B | 1.3B | 1.39B | 1.37B | 1.43B | 1.33B | 1.36B | 1.25B | 1.32B | 1.32B | 1.35B | 1.29B | 1.35B | 1.38B | 1.45B |
| Selling, General, and Administrative Revenue Growth | -4.19% | +3.56% | +1.65% | +4.27% | -1.04% | +3.05% | +0.57% | +7.65% | -0.06% | -1.39% | +0.98% | +2.69% | -2.32% | +4.34% | -2.31% | -1.71% | +7.58% | +8.82% | -5.30% | +4.32% | -1.19% | +4.38% | +0.29% | +2.79% | -2.99% | +5.31% | -6.61% | +1.38% | -3.92% | +7.20% | -2.13% | +8.70% | -5.22% | +0.15% | -2.51% | +5.29% | -4.53% | -2.46% | -4.76% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | 343M | n/a | n/a | n/a | 320M | n/a | n/a | n/a | 307M | n/a | n/a | n/a | 290M | n/a | n/a | n/a | 281M | n/a | n/a | n/a | 277M | n/a | n/a | n/a | 285M | n/a | n/a | n/a | 289M | n/a | n/a | n/a | 274M | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a |